SCHEMBL3710100

SCHEMBL3710100

Ic1ccc([C](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.52
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CES2 O00748 4/20 0.43
CES1 P23141 3/20 0.43
ITGA1 P56199 1/20 0.42
PDPK1 O15530 1/20 0.40
GSK3B P49841 1/20 0.39
TSHR P16473 2/20 0.39
DAO P14920 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SRD5A2 P31213 1/20 0.39
APP P05067 1/20 0.37
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36
F12 P00748 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4083603 0.88 TPMT (0.55) TPMTCA1CA2PDPK1GSK3B
SCHEMBL12331160 0.83 TPMT (0.52) TPMTCA1CA2CES2CES1
SCHEMBL143 0.82 CES1 (0.53) CA1CA2CES2CES1TSHR
SCHEMBL28629872 0.79 MEN1 (0.54) TPMTCA1CA2CES2CES1
SCHEMBL2479840 0.79 ALDH1A1 (0.70) TPMTCA1CA2CES2CES1
SCHEMBL2336841 0.79 CES2 (0.75) TPMTCA1CA2CES2CES1
Charcoal, Activated SCHEMBL30423229 0.78 CES1 (0.50) CA1CA2CES2CES1TSHR
Methane SCHEMBL29155195 0.78 CES1 (0.50) CA1CA2CES2CES1TSHR
Bromide SCHEMBL28972076 0.78 CES1 (0.50) CA1CA2CES2CES1TSHR
SCHEMBL28911317 0.78 CES1 (0.50) CA1CA2CES2CES1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393806-A1 INHIBITORS OF JUN N-TERMINAL KINASE Elan Pharmaceuticals Inc. (US) 2011-12-14 EP disclosed
WO-2010091310-A1 INHIBITORS OF JUN N-TERMINAL KINASE ELAN PHARMACEUTICALS, INC. (US) 2010-08-12 WO disclosed
EP-1960413-A2 MACROLIDES DERIVATIVES AS ANTIBACTERIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-08-27 EP disclosed
EP-1797043-A1 4-(PHENYLMETHYL AND SUBSTITUTED PHENYLMETHYL)-IMIDAZOLE-2-THIONES ACTING AS SPECIFIC ALPHA2 ADRENERGIC AGONISTS Allergan, Inc. (US) 2007-06-20 EP disclosed
WO-2007060618-A2 MACROLIDES DERIVATIVES AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2007-05-31 WO disclosed
WO-2006036480-A1 4-(PHENYLMETHYL AND SUBSTITUTED PHENYLMETHYL)-IMIDAZOLE-2-THIONES ACTING AS SPECIFIC ALPHA2 ADRENERGIC AGONISTS ALLERGAN, INC. (US) 2006-04-06 WO disclosed
CN-1285828-A Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom SCHERING CORP (US) 2001-02-28 CN disclosed